stress response. 17 Previous studies have shown that HO-1 expression is elevated in myocardial and smooth muscle cells from Bach1-deficient mice that are resistant to ischemic and proatherosclerotic stresses 18, 19 ; thus, Bach1 deficiency may protect these mice against oxidative tissue damage. [20] [21] [22] Bach1 is also known to inhibit oxidative stress-induced cellular senescence by impeding p53 function in murine embryonic fibroblasts, 23 and some Bach1 target genes are important regulators of cell cycle progression and apoptosis. 24 We have shown that Bach1 is expressed in human microvascular endothelial cells (HMVECs), 25 but the roles of Bach1 in endothelial function and angiogenesis have not been thoroughly studied, and the molecular targets of Bach1 in the vasculature are mostly unknown. Bach1 may regulate TCF4targeted genes because the results from a DNA array-based genome-wide analysis of TCF4 chromatin occupancy suggested that TCF4 binding regions are enriched with Bach1 DNA motifs, 26 but whether Bach1 interacts with the Wnt/β-catenin signaling pathway remains unclear. For the studies described in this report, we manipulated the level of Bach1 expression in cultured ECs and in the limbs of mice with peripheral ischemic injury to determine whether Bach1 has a role in angiogenesis and if so, whether its role is effected through changes in the Wnt/β-catenin signaling.
Methods
All studies were approved by the Ethics Committee of Experimental Research at Fudan University Shanghai Medical College, were consistent with the US National Institutes of Health Guide for the Care and Use of Laboratory Animals, and were performed via standardized protocols. Detailed descriptions of the mice, cells, reagents, and experimental methods are provided in the Online Data Supplement.
Results

Bach1 Suppresses the Angiogenic Response to Peripheral Ischemic Injury
To determine whether Bach1 regulates angiogenesis after ischemic injury, mice heterozygous for a Bach1 deletion mutation were interbred to generate homozygous Bach1-knockout mice (ie, the Bach1 -/group); then, hind-limb ischemia was surgically induced in Bach1 -/mice, in their littermates with wild-type (WT) levels of Bach1 expression (ie, the WT group), and in the C57BL/6J mice. Immediately after hind-limb ischemia induction, the injured limbs of the C57BL/6J mice were injected with adenoviruses coding for GFP (ie, the AdGFP group), for Bach1 (ie, the AdBach1 group), or saline (ie, the NS group; Online Figure IA ). Seven and 14 days later, blood flow measurements in the animals' ischemic limbs were significantly greater for Bach1 -/mice than for WT mice and significantly lower for mice in the AdBach1 group than for AdGFP or NS mice (Figure 1A) . Bach1 deficiency was also associated with significant increases in capillary density (Figure 1B ) and arteriole density (Figure 1C ) and in the expression of VEGF ( Figure 1D ) and a murine functional homologue of IL-8, keratinocyte-derived chemokine (KC) ( Figure 1E ), whereas the corresponding measurements were significantly lower in AdBach1 mice than in AdGFP mice. Expression of VEGF and KC in the animal's uninjured, contralateral limbs was also greater for the Bach1 -/group than for WT mice, whereas measurements in the uninjured limbs of AdBach1, AdGFP, and NS mice were similar ( Figure 1D and 1E ). Evaluations of GFP fluorescence and of the expression of the endothelial marker CD31 suggested that the vectors coding for Bach1 expression tended to be located in ECs (Online Figure IB) , and when rings of aortic tissues were excised from Bach1 -/and WT mice and cultured, significantly more angiogenic sprouting was observed from the aortic rings of Bach1 -/mice (Online Figure IC) .
Bach1 Reduces the Angiogenic Activity of ECs
Bach1 expression was observed in both the nucleus and cytoplasm of human umbilical vein ECs (HUVECs; Online Figure IIA , right) and HMVECs (data not shown) and was upregulated when the ECs were cultured under hypoxic conditions (Online Figure IIB) . The in vivo relevance of these observations was shown in WT C57BL/6J mice that exhibited a 7.6-fold increase in Bach1 expression in ischemic hindlimb muscles compared with nonischemic muscles (Figure 1A, right) . Furthermore, when the in vivo matrigel plug assay (Online Figure IIIA) was performed with HMVECs that had been transfected with AdBach1 or AdGFP and with HMVECs that had been transfected with Bach1 siRNA (Bach1siRNA) or a control siRNA (ConsiRNA), the higher levels of Bach1 expression were associated with declines in capillary density (Online Figure IIIB) and hemoglobin content (Online Figure  IIIC) . Thus, we conducted a series of experiments to determine whether the effect of Bach1 on angiogenesis and perfusion in mice with hind-limb ischemia can be attributed, at least in part, to changes in the angiogenic activity of ECs.
Assessments of tube formation, cell migration, and proliferation were significantly greater in lung ECs from Bach1 -/mice than in WT lung ECs (Figure 2A ), in Bach1siRNA-HUVECs than in ConsiRNA-HUVECs ( Figure 2B ; Online Figure IVD and IVE), and in AdGFP-HUVECs than in AdBach1-HUVECs ( Figure 2C ). Lower levels of Bach1 expression were also associated with significant increases in IL-8, KC, and VEGF expression ( Figure 2D ), whereas the effect of Bach1 silencing on tube formation was impaired by the inactivation of IL-8 or VEGF ( Figure 2E ). Bach1 overexpression led to an increase in apoptosis after 48 hours of culture (Online Figure IVB) , but proliferation measurements in cultured AdBach1-and AdGFP-HUVECs were similar for (at least) the first 24 hours (Online Figure IVC) , which suggests that the effect of Bach1 overexpression on endothelial-cell migration and tube formation (evaluated after 8-12 hours of culture) cannot be explained by declines in cell survival.
Bach1 Suppresses Wnt/β-Catenin Signaling in ECs
Endothelial tube formation, cell migration, and proliferation increased in Bach1siRNA-, ConsiRNA-, AdBach1-, and Figure 1 . Bach1 impedes angiogenesis after peripheral ischemic injury. Hind-limb ischemia (HLI) was surgically induced in 12-week-old Bach1 -/mice and their wild-type (WT) littermates and in 8-week-old C57BL/6J mice. Immediately after HLI induction, the injured limbs of the C57BL/6J mice were injected with adenoviruses coding for GFP (AdGFP), for Bach1 (AdBach1), or with saline (NS). A, On day 0, day 7, and day 14 after HLI, blood flow was evaluated via laser Doppler imaging and quantified for each animal as the ratio of measurements the injured (HLI) and uninjured (non-HLI) limbs (n=5 for Bach1 -/and WT mice, *P<0.05 vs WT; n=7 for AdGFP, AdBach1, and NS mice, **P<0.01 vs AdGFP; unpaired 2-tailed t test). On day 7, thigh adductor and gastrocnemius muscles were harvested from the limbs of C57BL/6 mice, and then Bach1 mRNA levels were analyzed with real-time polymerase chain reaction (PCR; n=5; **P<0.01 vs Non-HLI; unpaired 2-tailed t test). B and C, Fourteen days after HLI, adductor muscle was harvested from the HLI limb and stained for (B) CD31 and (C) α-smooth muscle actin (α-SMA) expression. B, Capillary density was calculated as the number of CD31 + vessels per mm 2 AdGFP-transfected HUVECs when the cells were cultured with Wnt3a, which is known to stimulate the angiogenic activity of ECs ( Figure 2B and 2C). However, the effect of Wnt3a stimulation was abolished by higher levels of Bach1 expression (Figures 2C; Online Figure IVA ). Moreover, knockdown of Bach1 expression in HUVECs promoted Wnt3a-stimulated angiogenic response ( Figure 2B ). Transcriptome analyses of AdBach1-and AdGFP-HMVECs indicated that Bach1 overexpression reduced the transcription of IL-8 more than the transcription of any other angiogenic cytokine tested (Online Table II ). IL-8 is known as Wnt/β-catenin downstream target gene. Canonical Wnt signaling prevents the destruction of β-catenin, which subsequently accumulates in the cytoplasm and translocates into the nucleus, where it functions as a coactivator of TCF/LEF-dependent transcription. 14 The promoter region of IL-8 contains a consensus TCF/LEF binding site from positions -186 to -177. Thus, we generated a series of luciferase reporter constructs containing the IL-8 promoter and then investigated the effect of Bach1 overexpression on the luciferase activity of these A B C D E F G H Figure 3 . Bach1 suppresses Wnt/β-catenin-induced transcriptional activation of interleukin-8 (IL-8). A, Luciferase promoter/reporter constructs were created containing the truncated (-1200, -500, -193, and -173) versions of the IL-8 promoter; then, the IL-8 promoter/ reporter or a pGL3-basic luciferase reporter and β-gal were cotransfected with a Bach1-coding vector or with an empty vector (control) into HEK293T cells, and luciferase activity was evaluated 36 hours later (n=3; **P<0.01 vs control; unpaired 2-tailed t test). B, Luciferase promoter/reporter constructs containing the wild-type (WT) IL-8(-193) sequence (TCF4 WT) or an IL-8(-193) sequence with a mutation at the TCF/LEF binding site (TCF4 mutant) were cotransfected with a Bach1-coding vector or an empty vector (control) into HEK293T cells, and luciferase activity was evaluated 36 hours later (n=3; **P<0.01 vs control; unpaired 2-tailed t test). C and D, Luciferase activity of the IL-8 (-193) promoter/reporter construct was evaluated in (C) HEK293T cells that had been transfected with an empty vector or with a Bach1-coding vector for 24 hours and incubated with or without Wnt3a for 12 hours (n=3; *P<0.05, **P<0.01 vs Wnt3a -/Bach1 -; ##P<0.01 vs Wnt3a + /Bach1 -; 1-way ANOVA), and in (D) HEK293T cells that had been transfected with an empty vector, with a vector coding for βcatenin, or with vectors coding for β-catenin and Bach1 (n=3; **P<0.01 vs β-catenin -/Bach1 -; #P<0.05, ##P<0.01 vs β-catenin + /Bach1 -; 1-way ANOVA). E and F, Luciferase activity of the IL-8 (-193) constructs. In HEK293T cells, Bach1 overexpression significantly reduced the luciferase activity of all promoter/reporter constructs that contained the TCF/LEF binding site (ie, -1200, -500, and -193) but did not reduce the luciferase activity of the -173 truncation, which lacked the TCF/LEF binding site ( Figure 3A ); Bach1 overexpression also failed to reduce the luciferase activity of the -193 truncation when the TCF/LEF site was mutated ( Figure 3B ). When Wnt signaling was stimulated by culturing the cells in Wnt3a ( Figure 3C ) or by cotransfecting the cells with a vector coding for β-catenin ( Figure 3D ), the luciferase activity of the (unmutated) -193 truncation was significantly lower in Bach1-overexpressing cells than in cells with endogenous levels of Bach1 expression. In HUVECs, the luciferase activity of the IL-8 promoter/reporter construct was lower in Bach1-overexpressing cells than in cells with endogenous levels of Bach1 expression ( Figure 3E ) and in ConsiRNA-HUVECs than in Bach1siRNA-HUVECs ( Figure 3F ). Higher levels of Bach1 expression also reduced IL-8 promoter activity when the cells were stimulated with Wnt3a, and the expression of 2 downstream targets of Wnt signaling, MMP3 ( Figure 3G ) and c-myc ( Figure 3H ), was lower in AdBach1-HUVECs than in AdGFP-HUVECs and in ConsiRNA-HUVECs than in Bach1siRNA-HUVECs. The results from IL-8 reporter assays were consistent with TOPflash assessments of Wnt signaling. TOPFlash activity increased significantly when HEK293T cells were stimulated with Wnt3a (Online Figure VA) or cotransfected with the β-catenin vector (Online Figure VB) , but measurements were significantly lower in Bach1-overexpressing cells than in cells with endogenous levels of Bach1 expression. In HUVECs, TOPflash activity was significantly lower in Bach1-overexpressing cells than in cells transfected with an empty vector and in ConsiRNA-HUVECs than in Bach1siRNA-HUVECs (Online Figure VC) ; higher levels of Bach1 expression also reduced TOPflash activity when HUVECs were stimulated with Wnt3a (Online Figure VD and VE). Collectively, the results from IL-8 promoter/reporter and TOPflash assays confirm that both endogenous and upregulated levels of Bach1 expression impede Wnt/β-catenin signaling.
Nonstandard Abbreviations and Acronyms
Bach1 Interacts With TCF4
The results from chromatin immunoprecipitation assays indicated that Bach1 occupies the region from position -193 to -1 of the IL-8 promoter in HUVECs (Online Figure VI) , which also contains the consensus TCF/LEF binding site. Thus, we conducted a series of coimmunoprecipitation and GSTpulldown assays to determine whether Bach1 interacts directly with TC4. TCF4 coprecipitated with Bach1 from the lysate of HUVECs under physiological conditions ( Figure 4A ), and exogenous TCF4 and Bach1 coprecipitated from the lysate of HEK293T cells that expressed Flag-tagged TCF4 (TCF4-Flag) and V5-tagged Bach1 (Bach1-V5; Figure 4B ); GST pulldown assays performed with the lysate from HEK293T cells confirmed that TCF4-Flag interacted directly with GSTtagged Bach1 (Bach1-GST; Figure 4C ).
Bach1 contains a BTB/POZ domain, which has been shown to have a role in transcriptional repression, as well as a bZip domain. 16 Thus, we determined which specific regions of Bach1 interacted with TCF4 by performing immunoprecipitation analyses in HEK293T cells that had been transfected A B C D Figure 4 . Bach1 interacts directly with TCF4. A, Bach1 was immunoprecipitated from the lysate of human umbilical vein endothelial cells (HUVECs); then, the precipitate was evaluated for the presence of TCF4 via Western blot. B, HEK293T cells were cotransfected with V5tagged Bach1 and an empty vector or Flag-tagged TCF4 and incubated for 48 hours; then, TCF4 was immunoprecipitated with anti-Flag, and the presence of Bach1 in the precipitate was evaluated with an anti-V5 antibody. C, HEK293T cells were transfected with TCF4-Flag and lysed; then, the lysate was incubated with GST or GST-tagged Bach1, the GST-bound proteins were eluted, and the presence of TCF4 was evaluated via Western blot with an anti-Flag antibody. D, HEK293T cells were transfected with 2 vectors, one coding for TCF4-HA, and the other coding for Flag-tagged versions of the full Bach1 sequence or mutant sequences lacking either the BTB domain or the bZip domain. The Bach1 was immunoprecipitated with an anti-Flag antibody, and TCF4 was detected in the precipitate with an anti-HA antibody.
by guest on November 18, 2017 http://circres.ahajournals.org/ Downloaded from with 2 vectors, one coding for TCF4-HA, and the other coding for Flag-tagged versions of the full Bach1 sequence or deletion sequences lacking either the BTB domain or the bZip domain. TCF4 coimmunoprecipitated with the full N-terminal Bach1 sequence and with the sequence that lacked the bzip domain but not with the sequence that lacked the BTB domain ( Figure 4D ). Thus, Bach1 binds directly with TCF4, and this interaction is mediated by the BTB domain in the N-terminal region of Bach1.
Bach1 Disrupts the Binding of β-Catenin to p300/CBP and Reduces β-Catenin Acetylation
Bach1 did not coprecipitate with β-catenin (data not shown), and Bach1 overexpression did not alter the amount of β-catenin located in the nucleus or in the cytoplasm of HEK293T cells (Online Figure VII) . However, Bach1 knockdown increased, whereas Bach1 overexpression reduced, the interaction between exogenous TCF4 and β-catenin in coprecipitation ( Figure 5A ) and GST-pulldown ( Figure 5B ) experiments with HEK293T cells. Because the affinity of β-catenin for TCF4 increases when β-catenin is acetylated, 27, 28 and β-catenin mediates Wnt signaling by recruiting transcriptional cofactors, such as p300 and CBP, 15 both of which can function as acetyltransferases, we investigated whether Bach1 may disrupt the interaction between β-catenin and p300/CBP and if so, whether this disruption inhibits β-catenin acetylation. When HEK293T cells were cotransfected with HA-tagged β-catenin (β-catenin-HA) and Flag-tagged CBP (CBP-Flag) and with Bach1-V5 or an empty vector, both the amount of β-catenin/ CBP coprecipitate ( Figure 5C ) and the amount of acetylated A B C E D Figure 5 . Bach1 disrupts the interaction between β-catenin and p300/CBP. A, left and middle, HEK293T cells that expressed βcatenin-HA and TCF4-Flag were transfected with control siRNA or Bach1siRNA and lysed; then, TCF4 was immunoprecipitated with an anti-Flag antibody and β-catenin was detected in the precipitant with an anti-HA antibody (n=3; **P<0.01; unpaired 2-tailed t test). A, right, HEK293T cells that expressed β-catenin-HA and TCF4-Flag were transfected with a control vector or a vector coding for Bach1-V5; then, β-catenin was immunuprecipitated with an anti-HA antibody, and TCF4 was detected in the precipitate with an anti-Flag antibody. B, HEK293T cells were transfected with vectors coding for β-catenin-HA or Bach1-V5 and lysed; then, the lysate was incubated with GST or GST-tagged TCF4, the GST-bound proteins were eluted, and the presence of β-catenin was evaluated via Western blot with an anti-HA antibody. C, HEK293T cells that expressed β-catenin-HA and CBP-Flag were transfected with an empty vector or a vector coding for Bach1-V5; then, CBP was immunoprecipitated with an anti-Flag antibody, and β-catenin was detected in the precipitant with an anti-HA antibody. D, HEK293T cells were transfected for 48 hours with vectors coding for β-catenin-HA, CBP-Flag, and Bach1-V5; then, the cells were lysed, and acetylated β-catenin was detected in the lysate with an antiacetyl-lysine49 β-catenin antibody. E, HEK293T cells that expressed β-catenin-HA and p300-Flag were transfected with an empty vector or a vector coding for Bach1-V5; then, p300 was immunoprecipitated with an anti-Flag antibody, and β-catenin was detected in the precipitant with an anti-HA antibody.
by guest on November 18, 2017 http://circres.ahajournals.org/ Downloaded from β-catenin ( Figure 5D ) were less in the Bach1-overexpressing cells. Bach1 overexpression also reduced the amount of βcatenin/p300 coprecipitate in HEK293T cells that had been cotransfected with β-catenin-HA and Flag-tagged p300 (p300-Flag; Figure 5E ).
Bach1 Increases HDAC Activity and Recruits HDAC1 to the IL-8 Promoter
The results from our coprecipitation experiments also indicated that Bach1 interacts with HDAC1, as reported previously, 23 in HUVECs ( Figure 6A ) and in HEK293T cells that had been cotransfected with Bach1-V5 and HAtagged HDAC1 (HDAC1-HA; Figure 6B ). Bach1 also increased HDAC activity in nuclear extracts from HUVECs ( Figure 6C ) and from HEK293T cells ( Figure 6D ), and this increase was abolished by culturing the cells with the HDAC inhibitor Trichostatin A or by transfecting the HEK293T cells with HDAC1 siRNA ( Figure 6E ). Furthermore, Trichostatin A treatment increased the transcriptional activity of the IL-8 promoter in Bach1-overexpressing HUVECs ( Figure 6F ), whereas chromatin immunoprecipitation assays indicated that HDAC1's occupancy of the IL-8 promoter was ≈2-fold greater in AdBach1-HUVECs than in AdGFP-HUVECs ( Figure 6G , left) and ≈3-fold lower in Bach1siRNA-HUVECs than in ConsiRNA-HUVECs ( Figure 6G, right) . In contrast, the enrichment of β-catenin,
A B
C D E F G Figure 6 . Bach1 recruits histone deacetylase 1 (HDAC1) to the interleukin-8 (IL-8) promoter and increases HDAC activity. A, Bach1 was immunoprecipitated from human umbilical vein endothelial cells (HUVECs), and the HDAC1 level in the precipitate was evaluated via Western blot. B, HEK293T cells were cotransfected with an empty vector and vectors coding V5-tagged Bach1 or HA-tagged HDAC1, as indicated, and incubated for 48 hours; then, HDAC1 was immunoprecipitated with an anti-HA antibody, and Bach1 was detected in the precipitate with an anti-V5 antibody. HUVECs (C) and HEK293T (D) cells were transfected with a Bach1-expressing vector or an empty vector for 24 hours; then, the cells were treated with Trichostatin A (TSA; 1 μmol/L) or DMSO (control) for 24 hours, and nuclear extracts were evaluated for HDAC activity (n=3; *P<0.05, **P<0.01 vs Bach1 -/TSA -; ##P<0.01 vs Bach1 + /TSA -; 1-way ANOVA). E, HEK293T cells were transfected with an empty vector, with a Bach1-V5-expressing vector, or HDAC1 siRNA or control siRNA as indicated for 48 hours; then, nuclear extracts were evaluated for HDAC activity (n=3; **P<0.01 vs Bach1 -/HDAC1siRNA -; ##P<0.01 vs Bach1 + / HDAC1siRNA -; 1-way ANOVA). F, HUVECs were transfected with an empty vector or a Bach1-expressing vector, as indicated, and with the IL-8 promoter/reporter construct; then, the cells were treated with or without TSA (1 μmol/L) for 24 hours and luciferase activity was quantified (n=3; **P<0.01 vs Bach1 -/TSA -; ##P<0.01 vs Bach1 + /TSA -; 1-way ANOVA). G, HUVECs were transfected with adenoviruses coding for GFP (AdGFP) or AdBach1 (left) or with ConsiRNA or BachsiRNA (right); then, chromatin immunoprecipitation was performed with antibodies against the indicated proteins. The amount of TCF4 DNA associated with each protein (relative to the total amount of DNA used) was determined via real-time polymerase chain reaction with a primer for the IL-8 (-193) H3, and H4 acetylation at these binding sites was decreased in AdBach1-HUVECs and was increased in Bach1siRNA-HUVECs ( Figure 6G ). Because HDACs most often function as transcriptional repressors, these observations suggest that HDAC1 may be a key component of the mechanism(s) by which Bach1 impedes gene transcription.
The Activation of Wnt Signaling Disrupts the Binding of Bach1 to TCF4 and the Recruitment of HDAC1 to the IL-8 Promoter
We investigated whether the activation of Wnt signaling disrupts the interaction between Bach1 and TCF4. The activation of Wnt signaling in HUVECs significantly increased IL-8 mRNA levels without altering Bach1 mRNA expression (Online Figure VIII) . Both Wnt3a treatment ( Figure 7A ) and β-catenin-HA transfection ( Figure 7B ) significantly reduced the amount of Bach1/TCF4 coprecipitate in HEK293T cells that had been cotransfected with Bach1-V5 and TCF4-Flag, and GST-pulldown assays confirmed that β-catenin overexpression reduced the interaction between Bach1-GST and TCF4-Flag ( Figure 7C ). Chromatin immunoprecipitation assays also suggested that Wnt3a treatment reduced Bach1 occupancy and HDAC1 occupancy of the IL-8 promoter, and these declines in occupancy were accompanied by increases in the acetylation of histones 3 and 4 and in the β-catenin in HUVECs ( Figure 7D ).
Discussion
Bach1 is known to be involved in the oxidative stress response, 20 and chromatin immunoprecipitation-coupled DNA microarray analyses suggest that a reasonably high proportion (≈16%) of binding sites for the Wnt signaling effector A B C D Figure 7 . Wnt3a and β-catenin disrupt the Bach1/TCF4 interaction and reduce histone deacetylase 1 (HDAC1) recruitment to the interleukin-8 (IL-8) promoter. A, HEK293T cells were transfected with vectors coding for Bach1-V5 and TCF4-Flag for 24 hours and then incubated with or without Wnt3a for 24 hours; then, the cells were lysed, TCF4 was immunoprecipitated from the lysate with an anti-Flag antibody and Bach1 was detected in the precipitate with an anti-V5 antibody (n=3; *P<0.05; unpaired 2-tailed t test). B, HEK293T cells were transfected with vectors coding for Bach1-V5, TCF4-Flag, and β-catenin-HA as indicated; then, TCF4 was immunoprecipitated with an anti-Flag antibody and Bach1 was detected in the precipitate with an anti-V5 antibody (n=3; *P<0.05; unpaired 2-tailed t test). C, HEK293T cells were transfected with vectors coding for TCF4-Flag and/or β-catenin-HA as indicated and lysed; then, the lysate was incubated with GST or GST-tagged Bach1, the GST-bound proteins were eluted, and TCF4 was detected with an anti-Flag antibody. D, HUVECs were incubated with or without Wnt3a for 24 hours; then, chromatin immunoprecipitation was performed with antibodies against the indicated proteins. The amount of TCF4 DNA associated with each protein (relative to the total amount of DNA used) was determined via real-time polymerase chain reaction with a primer for the IL-8 (-193) 26 However, the experiments described in this report are the first to investigate the role of Bach1 in angiogenesis and Wnt/β-catenin signaling pathway. Our findings demonstrate that Bach1 deficiency or lower levels of Bach1 expression are associated with greater perfusion and vascular density in mice with hind-limb ischemia, with increases in the angiogenic activity (eg, migration, proliferation, tube formation, and proangiogenic cytokine production) of ECs, and with higher levels of Wnt/β-catenin downstream target genes (eg, IL-8 and VEGF) in HUVECs. We also show that Bach1 binds directly to TCF4 and reduces the interaction of β-catenin with TCF4. Bach1 occupies the TCF4-binding site of the IL-8 promoter and recruits HDAC1 to the IL-8 promoter in HUVECs. Bach1 also prevents β-catenin from being acetylated by p300/CBP, whereas β-catenin can promote Wnt signaling by disrupting Bach1-TCF4 binding and HDAC1 recruitment. Collectively, these observations suggest that Bach1 suppresses angiogenesis after ischemic injury and impairs Wnt/β-catenin signaling by recruiting HDAC1 to the promoter of TCF4-targeted genes and by functioning as a competitive inhibitor of β-catenin/ TCF4 binding (Online Figure IX) . Bach1 is a crucial component of the mechanism by which the chemokine receptor CXCR3-B limits the proliferation of breast-cancer cells, 29 and deficiencies in Bach1 expression have been associated with increases in the survival of acute myeloid leukemia cells. 30 Both of these observations are consistent with the results from our in vitro studies: lower levels of Bach1 expression were associated with increases in the proliferation of HUVECs. However, Bach1 deficiency is associated with premature senescence in murine embryonic fibroblasts under conditions of oxidative stress, 23 which demonstrates that the effect of Bach1 on cell proliferation/survival can differ profoundly among cell types or experimental conditions. Nevertheless, both the experiments performed with murine embryonic fibroblasts and those presented here identify a link between Bach1's role in transcriptional repression and HDAC1 recruitment. Results from the murine embryonic fibroblast studies suggest that Bach1 blocks p53-programmed senescence by recruiting HDAC1 to the promoter of a subset of p53-targeted genes, 23 whereas our results indicate that Bach1 suppresses IL-8 transcription by, at least in part, recruiting HDAC1 to the IL-8 promoter and increasing HDAC activity. Notably, these observations are the first to suggest that Bach1 regulates HDAC activity although the specific intermolecular interactions or conformational changes involved have yet to be determined. HDACs also mediate the transcriptional repression of Raf kinase inhibitory protein by Bach1 in breast-cancer cells 31 ; thus, HDAC1 seems to be a common mediator of Bach1induced transcriptional repression.
Bach1 upregulation increases the level of reactive oxygen species in keratinocytes, 32 and high levels of reactive oxygen species impair neovascularization in the ischemic limbs of mice. 33, 34 We also found that Bach1 overexpression enhanced reactive oxygen species production and induced apoptosis in ischemic mouse hindlimbs (unpublished data). Furthermore, the results from one of our previous investigations suggest that Bach1 participates in arsenite-mediated angiogenesis by repressing the expression of HO-1, 25 which has been shown to promote neovascularization in ischemic hearts by upregulating VEGF. 35 The results presented here indicate that Bach1 overexpression in ECs reduces VEGF mRNA levels and that VEGF blockade abolishes the increased angiogenic activity observed in Bach1siRNA-transfected cells. IL-8 is another key mediator of angiogenesis, and the negative correlation between IL-8 (or KC) and Bach1 expression reported here has been previously observed when human ECs were cultured under hypoxic conditions: cellular levels of IL-8 declined, whereas Bach1 levels increased, in response to the activation of hypoxia-inducible factor-1. 36 IL-8 expression has also been linked to increases in the migration and tube formation of ECs, 37 and the results from our current study confirm that the effect of Bach1 silencing on tube formation in HUVECs can be abolished by blocking the activity of IL-8. However, neither HO-1 upregulation nor HO-1 inhibition alters IL-8 levels in human ECs, 36 and Bach1 overexpression inhibits tube formation in ECs from HO-1 knockout mice (unpublished results). Collectively, these observations suggest that Bach1 inhibits angiogenesis through at least 2 independent signaling pathways, one that is mediated by HO-1 and VEGF and another that involves IL-8, as well as by increasing reactive oxygen species production and apoptosis.
TCF/LEF act as transcriptional repressors by binding to Groucho/TLE proteins in the absence of nuclear β-catenin, whereas β-catenin directly displaces Groucho/TLE repressors from TCF/LEF in Wnt-mediated transcription activation. 14 Our results indicate that β-catenin competes with Bach1 in binding to the promoter of IL-8 gene when Wnt signaling is activated. We propose that Bach1 is an intrinsic factor that inhibits TCF4-mediated transcription when cells are quiescent. When the canonical Wnt/β-catenin signaling pathway is activated, β-catenin accumulates in the nucleus and removes Bach1 from the promoters of target genes to initiate gene transcription (Online Figure IX) .
In conclusion, the results presented here are the first to show that Bach1 suppresses angiogenesis after peripheral ischemic injury and that this function is associated with declines in Wnt/β-catenin target genes. Bach1 impairs Wnt/β-catenin signaling by disrupting the interaction between β-catenin and TCF4 and by recruiting HDAC1 to the promoter of TCF4targeted genes. Thus, Bach1 may be an appropriate target for angiogenic therapy or for the treatment of other disorders that involve aberrant regulation of Wnt/β-catenin pathway. 35 What Is Known?
• Wnt/β-catenin signaling promotes angiogenesis and vascular development. • The transcription factor BTB and CNC homology 1 (Bach1) is known to suppress oxidative stress responses.
What New Information Does This Article Contribute?
• Loss of Bach1 expression in mice enhances angiogenesis in the ischemic hindlimb. • Interleukin 8 and vascular endothelial growth factor are responsible for the antiangiogenic effect of Bach1 on human endothelial cells. • Bach1 suppresses Wnt/β-catenin signaling by disrupting the interaction between β-catenin and TCF4 and by recruiting histone deacetylase 1 to the promoter of TCF4-targeted genes.
Bach1 is a transcriptional repressor of antioxidative enzymes, such as heme oxygenase-1. The role of Bach1 in angiogenesis is unclear. In this study, we found that in mice the lack of Bach1 expression was accompanied by accelerated blood flow recovery from hind-limb ischemia, which was associated with a pronounced increase in angiogenesis. This enhanced neovascularization effect was associated with remarkable increase in the expression of a murine functional homologue of IL-8, keratinocyte-derived chemokine (KC), and vascular endothelial growth factor. In addition, the data from this study demonstrate that Bach1 suppresses Wnt/β-catenin signaling in endothelial cells by recruiting histone deacetylase 1 to the promoter of TCF4-targeted genes and by functioning as a competitive inhibitor of β-catenin/ TCF4 binding. Our study lends insight into the important roles of Bach1 in vascular cell biology and suggests that Bach1 may be a potential therapeutic target for angiogenic therapy or for the treatment of other disorders that involve aberrant regulation of Wnt/β-catenin pathway. In the Results section, two sentences should be corrected as follows: "Bach1 deficiency was also associated with significant increases… in the expression of VEGF ( Figure 1D ) and a murine functional homologue of IL-8, keratinocyte-derived chemokine (KC) ( Figure 1E )….Expression of VEGF and KC…" "Lower levels of Bach1 expression were also associated with significant increases in IL-8, KC, and…"
Novelty and Significance
In the Discussion section, the following changes have been made: "….between IL-8 and Bach1 expression reported here" has been corrected to "between IL-8 (or KC) and Bach1 expression."
In the Novelty and Significance section, the following changes have been made: "Interleukin 8 and vascular endothelial growth factor are responsible for the antiangiogenic effect of Bach1 on the endothelial cells" has been corrected to "…. on human endothelial cells." Also in the Novelty and Significance section, "the expression of interleukin 8 and vascular endothelial growth factor" has been corrected to "the expression of a murine functional homologue of IL-8, keratinocyte-derived chemokine (KC), and vascular endothelial growth factor."
The y-axes in the charts for Figure 1E and the top left panel of Figure 2D should be changed from "IL-8 mRNA Level" to "KC mRNA Level." The corresponding text in Figure 1E legend should be corrected to read: "(E) mRNA levels of the murine functional IL-8 homologue keratinocyte-derived chemokine (KC) were…" The corresponding text in Figure 2D legend should be corrected to read: "(D) mRNA or protein levels of IL-8, keratinocyte-derived chemokine (KC), and VEGF…"
In the Online Supplement, the primers used for qRT-PCR analyses of KC expression should be added to Online Cell culture 2 Primary human umbilical vein endothelial cells (HUVECs) were obtained from fresh umbilical cord veins from normal pregnancies informed consent was received; a procedure that was approved by the ethics review board of Fudan University. HUVECs were isolated by collagenase digestion as previously described. 1 HUVECs at passages one to five were used in the experiments. The HUVECs were identified as such by their typical cobblestonelike morphology, positive immunofluorescence staining for CD31, and uptake of acetylated low density lipoproteins (Online Figure IIA 
Construction of Vectors
Human Bach1 gene was generated and cloned into pcDNA3.1 as described previously. 4 The full-length cDNA of human TCF-4, -catenin, and HDAC1 were generated by PCR and verified by DNA sequencing. Hemagglutinin (HA) or Flag-epitope tags were introduced to the C termini of these molecules. pCMV or pcDNA3 plasmid is the vector for the expression constructs. 
Transient transfection and luciferase assay
Transient transfection and luciferase assay were performed as described previously. 5 Cells were transfected with DNA or siRNA together with the indicated reporter or pGL3-basic luciferase reporter and -galactosidase plasmid using Lipofectamine 2000. The transfected cells were cultured for 36 hours. 4 Cells were harvested and measured with a luciferase assay kit (Promega, Madison, WI). Relative luciferase activity was calculated as the ratio of Luc/-galactosidase activity, and expressed as the ratio of IL-8 reporter/pGL3-basic or TOPflash/FOPflash. Each experiment was repeated three independent times.
Quantitative real time reverse transcription-polymerase chain reaction
The expression levels of various genes were analyzed by real time reverse transcription-polymerase chain reaction (RT-PCR) as described previously. 6 Total RNA was extracted using the TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. cDNA was synthesized using SuperScript Reverse Transcriptase (Fermentas, Glen Burnie, MD). RT-PCR analysis was carried out using SYBR Green PCR master mix (Toyobo, Japan). Primers are shown in Online Table I. All samples were analyzed using a Bio-Rad real-time analyzer (Bio-Rad Laboratories, Hercules, CA) and results were normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. Each experiment was repeated three independent times.
Western blotting
Western blotting was performed as described previously. 7 Briefly, cells or tissue homogenates were lysed with SDS sample buffer on ice for 10 minutes. Samples were heated at 95 °C for five minutes and subjected for 10 minutes to centrifugation at 10,000g. SDS-PAGE was performed and proteins were detected using their respective antibodies. Chemiluminescence was detected on a Tanon-5500 Imaging System (Tanon Science & Technology Ltd, Shanghai, China). The intensity of the bands was measured via densitometric analysis with ImageJ software, and normalized to the control. Each experiment was repeated three independent times.
Cell migration assay
Migration of ECs was determined by using transwell chambers (24-well plates, 8-μm pore size, Corning Inc., NY) as described previously. 5 The top well was loaded with 1×10 5 cells containing EBM-2 with 0.1% FCS. 2% FCS was used in the bottom chamber as the attractant. After incubation for eight hours at 37°C, the nonmigrating cells on the upper side of the chamber were mechanically removed and the remaining cells on the lower side were fixed with 4% formaldehyde and stained with 0.1% crystal violet.
Migrating cells on the bottom side of the chamber were counted manually in five random microscopic fields. Each experiment was repeated three independent times.
Cell proliferation assay
EC proliferation was analyzed by bromodeoxyuridine (BrdU) incorporation into newly synthesized DNA.
ECs were seeded in a 96-well plate in culture medium at the indicated time points. BrdU was added and incubated with the cells for six hours. BrdU incorporation was determined according to the manufacturer's instructions (Calbiochem, San Diego, CA). The absorbance was measured at 450 nm using a spectrophotometer microplate reader. The assays were carried out in sextuplicate. Each experiment was repeated three independent times.
Cell apoptosis assay
ECs were harvested and incubated with propidium iodide and annexin V-fluorescein isothiocyanate for 15 minutes at 37 °C . The samples were then analyzed by using a flow cytometer (Beckman Coulter). The percentage of annexin V-positive cells (earlier apoptotic cells) of total cells was calculated. Each experiment was repeated three independent times.
Tube formation assay
ECs were cultured in a 48-well plate coated with 200 μL of growth factor-reduced Matrigel. Tube length was quantified after 12 hours by measuring the cumulative tube length in five random microscopic fields with an inverted phase contrast microscope using ImageJ software. The relative tube lengths were expressed as the fold change relative to the control. Each experiment was repeated three independent times. 6 
Immunoprecipitation and in-vitro binding experiment
HEK293T cells were transiently transfected with the indicated constructs for 36 hours. The immunoprecipitation experiment was then performed as described previously. 8 For the in-vitro binding experiment, GST-fused proteins were expressed in Escherichia coli and purified by glutathione-Sepharose 4B beads. The proteins were incubated with glutathione-Sepharose 4B beads for four hours at 4 °C. The beads were washed and incubated with target proteins for 12 hours at 4 °C. The beads were washed three times and resuspended in 40 L SDS loading buffer. SDS-PAGE was performed and proteins were detected using their respective antibodies. Each experiment was repeated three independent times.
Chromatin Immunoprecipitation (ChIP)
The assay was performed according to the manufacturer's protocol (ChIP-IT protein G magnetic beads kit, Active Motif, Carlsbad, CA). In brief, cells were seeded onto a 10 cm tissue culture dish, and one day later were cross-linked by 1% formaldehyde for 10 minutes at room temperature and followed by fragmentation of genomic DNA using a sonification apparatus. Cell lysates were used for chromatin immunoprecipitation using Bach1, HDAC1, Ac-Histone H3, Ac-Histone H4, -catenin, and control antibodies. The protein G magnetic beads-antibody/chromatin complexes were washed and the antibody/chromatin complexes were subsequently eluted. The cross linked protein/DNA complexes were detached at 65°C for four hours followed by purification of the genomic DNA. PCR primers amplifying the IL-8 and glyceraldehyde phosphate dehydrogenase (GADPH) promoters are shown in Online Table I. Real time PCR was carried out using SYBR Green PCR master mix. The amount of DNA associated with each protein (relative to the total amount of DNA used) was determined. Each experiment was repeated three independent times.
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HDAC enzymatic-activity assay
Total cellular HDAC enzymatic activity was measured using an HDAC assay kit (Millipore, Billerica, MA). Briefly, nuclear protein was extracted from cells. 5 g of control or TSA-treated cell nuclear extracts were incubated in a 96-well plate with a fluorometric substrate in HDAC assay buffer for 45 minutes at 37°C. An activator solution was then added to release the fluorophore from the deacetylated substrates, and the fluorescence was measured in a plate-reading fluorimeter (excitation, 390 nm; emission detection, 460 nm), and expressed as percent increase over the control. Each experiment was repeated three independent times.
Measurement of secreted IL-8 via ELISA
The secreted IL-8 in ECs was quantified in the cell culture supernatant using an ELISA assay kit (Neobioscience Technology, Shengzhen, China). ECs were transfected with siRNA or transduced with adenovirus. After 24 hours, cells were washed with phosphate buffered saline (PBS) and fresh medium was added. Supernatants of the cells were collected at 48 hours and the number of cells was counted. An ELISA assay was performed according to the manufacturer's protocol. After measuring the IL-8 content in the supernatants, the amount of IL-8 per 10 6 cells was calculated. Each experiment was repeated three independent times.
Murine aortic ring assay
Aortas were removed from 12-week-old wild-type (WT) and Bach1 -/littermates, 1-mm segments were placed in 100 L cold Matrigel in a 96-well plate in EBM-2 endothelial cell basal medium, and the medium was changed every other day. The aortic rings were photographed at day 7 by phase-contrast microscopy. The areas of sprout were calculated with the use of at least 8 segments of aorta from each mouse. The relative areas of sprout were normalized by WT group from three mice per group.
In-vivo Matrigel plug assay with transfected HMVECs
This assay was carried out as described previously with the following modifications 9 : HMVECs were transfected with siRNA or transduced with adenovirus as described above. After 24 hours, cells were resuspended in 100 μL PBS and mixed with 400 μL Matrigel in the absence or presence of VEGF (100 ng/mL). The cell-Matrigel-mixture was injected subcutaneously into six-week old female BALB/c nude mice along the abdominal midline. After seven days, the intact Matrigel plugs were collected and photographed. Plugs were embedded and dissected and the sections were stained with CD31. For hemoglobin analysis, the excised Matrigel plug was homogenized in 100 μL PBS. After centrifugation, the supernatant was used in the Drabkin assay to measure hemoglobin concentration. Stock solutions of hemoglobin were used to generate a standard curve. Hemoglobin content (mg) was expressed relative to the weight of the plug (g).
Murine ischemic hindlimb model
The mice underwent unilateral femoral artery ligation as described. 10 Briefly, following anesthesia with sodium pentobarbital (50 mg/kg i.p.), the left femoral artery was exposed under a dissection microscope.
The proximal femoral artery and the distal portion of the saphenous artery were ligated and arteriectomy was performed. In Bach1 overexpression experiments, an adenovirus vector carrying Bach1 (Ad-Bach1), the control vector (Ad-GFP), or the saline was injected at two sites of the adductor muscle and at two sites into gastrocnemius muscle (total Ad dose: 2×10 8 plaque-forming units in 40 L). Sham operation was performed without femoral artery ligation but skin incision. Blood flow recovery to the ischemic foot was sequentially monitored by a MoorLDI2-2 laser Doppler imaging system (Moor Instruments, Devon, UK) up to 14 days after ischemia. Mice were euthanized and maintained at 37°C on a heating plate to minimize temperature variation. Ischemic and nonischemic limb perfusion was measured pre-, postsurgery, seven days, and two weeks after surgery. Final blood flow values were expressed as the ratios of ischemic to non-ischemic hindlimb perfusion. Mice were sacrificed on day seven or 14 post-surgery and 9 adductor muscles were harvested, the formaldehyde was fixed, and the paraffin was embedded.
Capillaries in tissue sections were stained using a CD31 antibody and arterioles were visualized using an -smooth muscle actin (SMA) antibody. Capillary or arteriole density was assessed by counting the number of capillaries or arterioles in five high-powered fields in each of the four tissue sections (per mouse) and then expressing the data as CD31 + vessels per mm 2 or -SMA + vessels per mm 2 .
Isolation and culture of ECs from murine lung
Endothelial cells were isolated and purified with some modifications of previously described method. 11 Briefly, 12-week-old C57 BL/6 (WT) or Bach1 -/mice (n= 3/group) were sacrificed by an overdose of isoflurane. The lungs were removed, minced to 1 mm-sized pieces, washed in Hank's Balanced Salt Solution, and filtered through a 40 m nylon-mesh cell strainer. The tissue was digested in 20 mL Collagenase for 1 h at 37°C and the homogenate was further filtered through the cell-strainer and centrifugated at 290 g for 5 min. The resulting pellet was then washed with phosphate-buffered saline supplemented with 0.1% bovine serum albumin (PBS/BSA) and the cell suspension was incubated with rat anti-mouse PECAM-1 antibody (553369, BD Pharmigen)-coated magnetic beads (sheep anti-rat;
Dynal) for 1 h on Dynalmixer. The magnetic beads were washed four times with PBS/BSA on Dynal-MPC and finally resuspended in D-MEM/F12 culture medium containing 20% fetal bovine serum (FBS, Cambrex), endothelial cell growth factor with heparin (ECGS-H, 8L/mL; Promo cell), penicillin (100U/mL ) and streptomycin (100g/mL; Invitrogen) and plated on gelatin (Sigma Aldrich) coated dishes. Cells were re-purified with ICAM2 antibody (553325, BD Pharmigen)-coated magnetic beads during the first two passages and cells from the third passage were used for experiments. Cells were phenotyped by functional uptake of acetylated LDL and CD31 staining. 90-95% of the cells were positive for ECs markers (Dil-Ac-LDL or CD31). Cells from the 3rd-8th passage were used in all experiments.
Immunofluorescence and immunohistochemistry staining
Paraffin sections were deparaffinized, rehydrated, and analyzed by immunofluorescence. Briefly, the sections were incubated with primary antibodies in blocking solution overnight. The secondary antibody was a conjugate of Cy3 donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA). DAPI was used as nuclear counter-staining. The stained sections were examined under a fluorescence microscope (Olympus, Tokyo, Japan). For immunohistochemical analyses, primary antibodies were sequentially stained with HRP-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA). The stain was then developed with a DAB Substrate Kit (Beyotime, Shanghai, China) and tissues were counterstained with hematoxylin.
Statistical analysis
Data are expressed as mean±SEM from in the Figures. Differences among groups were determined using Prism software with one-way analysis of variance followed by Bonferroni post hoc test. Differences between two groups were assayed by two-tailed student t-test. The 0.05 level of probability was used as the criterion of significance. In the absence of Wnt signaling (left), Bach1 interacts with TCF4 on the promoters of Wnt-targeted genes (e.g. IL-8) and inhibits transcription by recruiting HDAC1. When Wnt signaling is activated (right), catenin translocates into the nucleus and displaces Bach1 from TCF4, which enables the -catenin/TCF4 complex to bind the promoter and activate gene transcription. 
Online
Online Figure I
